ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 64 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 2.60 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $2,000 | -50.0% | 50 | -94.7% | 0.00% | 0.0% |
| Q4 2018 | $4,000 | -50.0% | 950 | 0.0% | 0.00% | -50.0% |
| Q3 2018 | $8,000 | -20.0% | 950 | 0.0% | 0.00% | -33.3% |
| Q2 2018 | $10,000 | -99.9% | 950 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $8,256,000 | -30.6% | 950 | 0.0% | 0.00% | -25.0% |
| Q4 2017 | $11,894,000 | +2745.5% | 950 | +1800.0% | 0.00% | – |
| Q3 2017 | $418,000 | -50.8% | 50 | 0.0% | 0.00% | – |
| Q2 2017 | $849,000 | -15.6% | 50 | 0.0% | 0.00% | – |
| Q1 2017 | $1,006,000 | – | 50 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AdvisorShares Investments LLC | 610,045 | $2,014,000 | 0.47% |
| ETF MANAGERS GROUP, LLC | 1,814,328 | $5,987,000 | 0.13% |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 72,169 | $238,000 | 0.06% |
| Bernardo Wealth Planning LLC | 27,219 | $89,000 | 0.03% |
| Affinity Asset Advisors, LLC | 13,285 | $44,000 | 0.02% |
| ALGERT GLOBAL LLC | 20,778 | $69,000 | 0.02% |
| ZEKE CAPITAL ADVISORS, LLC | 49,700 | $164,000 | 0.01% |
| Founders Capital Management | 2,000 | $18,000 | 0.01% |
| King Wealth Management Group | 16,000 | $53,000 | 0.01% |
| Penserra Capital Management LLC | 129,252 | $425,000 | 0.01% |